Better management of patients with overactive bladder with antimuscarinics?
MacDiarmid
S
S
D000279:Administration, Cutaneous; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D008333:Mandelic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D008333:Mandelic Acids; D018727:Muscarinic Antagonists; C005419:oxybutynin